Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 14/20 | 0.68 |
| ▸ | CTSL | P07711 | 2/20 | 0.68 |
| ▸ | CTSB | P07858 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CTSG | P08311 | 1/20 | 0.68 |
| ▸ | CAPN9 | O14815 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11208009 | 0.85 | CAPN1 (0.74) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL2315130 | 0.84 | CAPN1 (0.64) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL21396087 | 0.82 | CAPN1 (0.70) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL10863647 | 0.82 | CAPN1 (0.70) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL10863642 | 0.82 | CAPN1 (0.70) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL7400493 | 0.82 | CAPN1 (0.70) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL10863655 | 0.82 | CAPN1 (0.70) | CAPN1CTSLCTSBLMNACTSG | |
| SCHEMBL11194087 | 0.81 | CAPN1 (0.68) | CAPN1CTSLCTSBLMNACTSG | |
| Aloxistatin SCHEMBL21981210 | 0.81 | CAPN1 (1.00) | CAPN1CTSLCTSBLMNACTSG | |
| Aloxistatin SCHEMBL21981208 | 0.81 | CAPN1 (1.00) | CAPN1CTSLCTSBLMNACTSG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010063839-A2 | TARGETS FOR TREATMENT OF CHLAMYDIAL INFECTIONS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2010-06-10 | — | — | WO | disclosed |